Fact CheckerSign in

NCT06604468Recruiting

A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients

Source: ClinicalTrials.gov · Last updated 6 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's measurements match those obtained from lung ultrasound and other imaging techniques. By detecting lung fluid build-up before symptoms worsen, this device could help manage heart failure more effectively outside of hospital settings, potentially improving patient care and reducing hospital admissions. Participants in the study are monitored using this device along with standard imaging methods, and data on heart failure symptoms are collected to understand the device\'s accuracy and usability.

Status (registry)
Recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
17 Sept 2024
Start date
1 Sept 2025
Primary completion date
30 Jun 2026
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
NCT number
NCT06604468

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 1 Sept 2025 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnant women at the time of eligibility evaluation.
  • Presence of an implanted electronic device in the thorax, such as a pacemaker or defibrillator.
  • Inability to provide informed consent.
  • Admission to intensive care or the coronary care unit.

Who the study is looking for

  • Adults aged 18 years or older.
  • Diagnosed with heart failure, defined by the following criterion: hospitalization or an emergency visit for decompensated heart failure (pulmonary edema) within the last 12 months.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHUM
Coordinator of this site? Confirm its status
MontrealCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.